News & Updates

How safe is sacubitril-valsartan plus spironolactone for ADHF?
How safe is sacubitril-valsartan plus spironolactone for ADHF?
04 Jan 2025

Initiation of sacubitril-valsartan with spironolactone during hospitalization for acute decompensated heart failure (ADHF) does not result in more adverse drug reactions (ADRs), reports a study. However, patients on this regimen tend to develop hyperkalemia.

How safe is sacubitril-valsartan plus spironolactone for ADHF?
04 Jan 2025
NT-proBNP predicts cardiorenal complications in Chinese patients with T2D
NT-proBNP predicts cardiorenal complications in Chinese patients with T2D
30 Dec 2024 byChristina Lau

Elevated N-terminal pro–B-type natriuretic peptide (NT-proBNP) levels independently predict cardiorenal complications in Chinese patients with type 2 diabetes (T2D) and can be utilized as a clinical prognostic biomarker for risk stratification to enable more intensive organ-protective treatment in those at risk, a study involving 1,993 patients enrolled in the Hong Kong Diabetes Biobank has shown.

NT-proBNP predicts cardiorenal complications in Chinese patients with T2D
30 Dec 2024
Volatile organic compounds up hypertension risk
Volatile organic compounds up hypertension risk
27 Dec 2024

A recent study has found epidemiological evidence pointing to an association between environmental pollutants and hypertension. This finding calls attention to the contribution of nonoccupational volatile organic compounds (VOCs) to the risk of hypertension in the general population.

Volatile organic compounds up hypertension risk
27 Dec 2024